Article Listing - Abbott Labs' 3rd-qtr beats earnings expectations but group sales disappoint

EFPIA PRESIDENT DEFENDS PHARMA IND

20 April 1992

In the pharmaceutical sector, research and development spending is now so "repressive" that there is little chance of a reasonable...

ABPI WARNING ON COUNTERFEIT DRUGS

20 April 1992

The Association of the British Phar-maceutical Industry has called for more stringent controls on imported pharmaceuticals, although admitting that National...

IMEX HEMOFARM IN MOSCOW

20 April 1992

The Imex Hemofarm pharmaceutical concern based in Vrsac in Serbia has opened a representative office in Moscow in order to...

STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB

20 April 1992

New sales and earnings records were achieved by the US pharmaceutical concern Bristol-Myers Squibb in 1991, according to its annual...

JAPANESE THREAT "INTENSIFYING"

20 April 1992

Japanese pharmaceutical companies must be regarded as world market competitors more speedily than had originally been expected, according to Hans...

ISRAEL SICK FUND MEMBERS SURVEYED

20 April 1992

Yediot Aharonot, Israel's leading daily newspaper, has published results of a survey by the Brendman Institute into Israeli public attitudes...

STOCK MARKET COMMENTARY: EUROPE

20 April 1992

EUROPE: saw most of its stock markets down on the week, following the free-fall in Tokyo and poor performance of...

BOEH MANNHEIM/RATIO LEGAL BATTLE

20 April 1992

The role of the German drug law in possibly creating conditions where drugs can be modified and marketed without regulatory...

NEW PRESIDENT FOR STERLING HEALTH CANADA

20 April 1992

Robert Steinman has been named as president of non-prescription drug company Sterling Health Canada.

APPOINTMENTS IN WYETH-AYERST GROUP

20 April 1992

Etienne Attar has been promoted to vice president, sales and marketing at Ayerst Laborat-ories in Canada. He succeeds Jeff Boily,...

Showing 94161-94170 of 95316 articles